Stock image

March 5, 2012 —Parascript LLC announced the latest version of its computer-aided detection (CAD) technology for mammography. AccuDetect 6.1 offers radiologists continued improvements in sensitivity and specificity in detecting suspicious lesions on mammograms.

Parascript AccuDetect is intended for use in screening mammography to identify suspicious areas for breast cancer. The technology can help to prompt closer examination of a potential lesion that a radiologist may have overlooked in an initial read. Digital mammography images are automatically analyzed to identify suspicious areas for possible soft tissue densities and/or calcifications and enable a more accurate interpretation of mammograms.

AccuDetect 6.1 uses proprietary pattern recognition and image processing technology to detect the presence of suspicious lesions on mammogram images and is more robust, with significantly higher performance compared to the previous version. The result is a CAD product with high sensitivity and low false-positive rates.

It is available in Europe to digital mammography equipment vendors to integrate with DR (direct radiography) and CR (computer radiography) systems.

For more information: www.parascript.com


Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 05, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
Subscribe Now